Antigen processing patterns determine GAD65-specific regulation vs. pathogenesis

Frontiers in Bioscience

Volumn 14, Issue 1, 2009, Pages 344-351

  Dai, Yang D ^a   Sercarz, Eli E ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

Antigen; Determinant; Epitope; GAD65; NOD mouse; Presentation; Processing; Review; Type 1 diabetes

Indexed keywords

GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2;

ANIMAL; GENE INACTIVATION; HUMAN; IMMUNOLOGY; REGULATORY T LYMPHOCYTE; REVIEW; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; GENE KNOCKOUT TECHNIQUES; GLUTAMATE DECARBOXYLASE; HUMANS; T-LYMPHOCYTES, REGULATORY;

EID: 63849281566     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3248     Document Type: Article

References (52)

1. Baekkeskov, S., J. H. Nielsen, B. Marner, T. Bilde, J. Ludvigsson, A. Lernmark: Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 298:167(1982)
2. Kash, S. F., B. G. Condie, S. Baekkeskov: Glutamate decarboxylase and GABA in pancreatic islets: lessons from knock-out mice. Horm Metab Res 31:340(1999)
3. Kubosaki, A., J. Miura, A. L. Notkins: IA-2 is not required for the development of diabetes in NOD mice. Diabetologia 47:149(2004)
4. Kubosaki, A., S. Nakamura, A. L. Notkins: Dense core vesicle proteins IA-2 and IA-2beta: metabolic alterations in double knockout mice. Diabetes 54 Suppl 2:S46(2005)
5. Bridgett, M., M. Cetkovic-Cvrlje, R. O'Rourke, Y. Shi
6. Narayanswami, J. Lambert, V. Ramiya, S. Baekkeskov, E. H. Leiter: Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells. Diabetes 47:1848(1998)
7. Jaeckel, E., L. Klein, N. Martin-Orozco, H. von Boehmer: Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase. J Exp Med 197:1635(2003)
8. Yoon, J. W., C. S. Yoon, H. W. Lim, Q. Q. Huang, Y. Kang, K. H. Pyun, K. Hirasawa, R. S. Sherwin, H. S. Jun: Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science 284:1183(1999)
9. Lernmark, A.: Glutamic acid decarboxylase-gene to antigen to disease. J Intern Med 240:259(1996)
10. Fenalti, G., R. H. Law, A. M. Buckle, C. Langendorf, K. Tuck, C. J. Rosado, N. G. Faux, K. Mahmood, C. S. Hampe, J. P. Banga, M. Wilce, J. Schmidberger, J. Rossjohn, O. El-Kabbani, R. N. Pike, A. I. Smith, I. R. Mackay, M. J. Rowley, J. C. Whisstock: GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop. Nat Struct Mol Biol 14:280(2007)
11. Kaufman, D. L., M. Clare-Salzler, J. Tian, T. Forsthuber, G. S. Ting, P. Robinson, M. A. Atkinson, E. E. Sercarz, A. J. Tobin, P. V. Lehmann: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69(1993)
12. Fenalti, G., C. S. Hampe, Y. Arafat, R. H. Law, J. P. Banga, I. R. Mackay, J. C. Whisstock, A. M. Buckle, M. J. Rowley: C-terminal clustering of autoantibody and T cell determinants on the structure of GAD65 provide insights into the molecular basis of autoreactivity. Diabetes (2008)
13. Quinn, A., M. F. McInerney, E. E. Sercarz: MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity. J Immunol 167:1748(2001)
14. Han, G., Y. Li, J. Wang, R. Wang, G. Chen, L. Song, R. Xu, M. Yu, X. Wu, J. Qian, B. Shen: Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD500-585. J Immunol 174:4516(2005)
15. James, E. A., W. W. Kwok: CD8+ suppressormediated regulation of human CD4+ T cell responses to glutamic acid decarboxylase 65. Eur J Immunol 37:78(2007)
16. Busick, R. Y., C. Aguilera, A. Quinn: Dominant CTL-inducing epitopes on GAD65 are adjacent to or overlap with dominant Th-inducing epitopes. Clin Immunol 122:298(2007)
17. Weaver, D. J., Jr., B. Liu, R. Tisch: Plasmid DNAs encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice. J Immunol 167:586(2001)
18. Tisch, R., X. D. Yang, S. M. Singer, R. S. Liblau, L. Fugger, H. O. McDevitt: Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366:72(1993)
19. Zekzer, D., F. S. Wong, O. Ayalon, I. Millet, M. Altieri, S. Shintani, M. Solimena, R. S. Sherwin: GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice. J Clin Invest 101:68(1998)
20. Chao, C. C., H. K. Sytwu, E. L. Chen, J. Toma, H. O. McDevitt: The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire. Proc Natl Acad Sci U S A 96:9299(1999)
21. Chao, C. C., H. O. McDevitt: Identification of immunogenic epitopes of GAD 65 presented by Ag7 in non-obese diabetic mice. Immunogenetics 46:29(1997)
22. Kim, S. K., K. V. Tarbell, M. Sanna, M. Vadeboncoeur, T. Warganich, M. Lee, M. Davis, H. O. McDevitt: Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells. Proc Natl Acad Sci U S A 101:14204(2004)
23. Tarbell, K. V., M. Lee, E. Ranheim, C. C. Chao, M. Sanna, S. K. Kim, P. Dickie, L. Teyton, M. Davis, H. McDevitt: CD4 (+) T cells from glutamic acid decarboxylase (GAD) 65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer. J Exp Med 196:481(2002)
24. You, S., C. Chen, W. H. Lee, T. Brusko, M. Atkinson, C. P. Liu: Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice. J Immunol 173:6777(2004)
25. Tian, J., M. Clare-Salzler, A. Herschenfeld, B. Middleton, D. Newman, R. Mueller, S. Arita, C. Evans, M. A. Atkinson, Y. Mullen, N. Sarvetnick, A. J. Tobin, P. V. Lehmann, D. L. Kaufman: Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat Med 2:1348(1996)
26. Olcott, A. P., J. Tian, V. Walker, H. Dang, B. Middleton, L. Adorini, L. Washburn, D. L. Kaufman: Antigen-based therapies using ignored determinants of beta cell antigens can more effectively inhibit late-stage autoimmune disease in diabetes-prone mice. J Immunol 175:1991(2005)
27. Quinn, A., M. McInerney, D. Huffman, B. McInerney, S. Mayo, K. Haskins, E. Sercarz: T cells to a dominant epitope of GAD65 express a public CDR3 motif. Int Immunol 18:967(2006)
28. Quinn, A., B. McInerney, E. P. Reich, O. Kim, K. P. Jensen, E. E. Sercarz: Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes. J Immunol 166:2982(2001)
29. Kedl, R. M., W. A. Rees, D. A. Hildeman, B. Schaefer, T. Mitchell, J. Kappler, P. Marrack: T cells compete for access to antigen-bearing antigen-presenting cells. J Exp Med 192:1105(2000)
30. Wegmann, D. R., M. Norbury-Glaser, D. Daniel: Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur J Immunol 24:1853(1994)
31. Daniel, D., D. R. Wegmann: Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci U S A 93:956(1996)
32. Daniel, D., R. G. Gill, N. Schloot, D. Wegmann: Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 25:1056(1995)
33. Jasinski, J. M., L. Yu, M. Nakayama, M. M. Li, M. A. Lipes, G. S. Eisenbarth, E. Liu: Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout. Diabetes 55:1978(2006)
34. Zekzer, D., F. S. Wong, L. Wen, M. Altieri, T. Gurlo, H. von Grafenstein, R. S. Sherwin: Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse. Diabetes 46:1124(1997)
35. Du, W., F. S. Wong, M. O. Li, J. Peng, H. Qi, R. A. Flavell, R. Sherwin, L. Wen: TGF-beta signaling is required for the function of insulin-reactive T regulatory cells. J Clin Invest 116:1360(2006)
36. Nakayama, M., N. Abiru, H. Moriyama, N. Babaya, E. Liu, D. Miao, L. Yu, D. R. Wegmann, J. C. Hutton, J. F. Elliott, G. S. Eisenbarth: Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435:220(2005)
37. Katz, J. D., B. Wang, K. Haskins, C. Benoist, D. Mathis: Following a diabetogenic T cell from genesis through pathogenesis. Cell 74:1089(1993)
38. Haskins, K., M. Portas, B. Bergman, K. Lafferty, B. Bradley: Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc Natl Acad Sci U S A 86:8000(1989)
39. Hoglund, P., J. Mintern, C. Waltzinger, W. Heath, C. Benoist, D. Mathis: Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 189:331(1999)
40. Judkowski, V., C. Pinilla, K. Schroder, L. Tucker, N. Sarvetnick, D. B. Wilson: Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J Immunol 166:908(2001)
41. Yoshida, K., T. Martin, K. Yamamoto, C. Dobbs, C. Munz, N. Kamikawaji, N. Nakano, H. G. Rammensee, T. Sasazuki, K. Haskins, H. Kikutani: Evidence for shared recognition of a peptide ligand by a diverse panel of nonobese diabetic mice-derived, islet-specific, diabetogenic T cell clones. Int Immunol 14:1439(2002)
42. Dai, Y. D., K. P. Jensen, A. Lehuen, E. L. Masteller, J. A. Bluestone, D. B. Wilson, E. E. Sercarz: A peptide of glutamic acid decarboxylase 65 can recruit and expand a diabetogenic T cell clone, BDC2.5, in the pancreas. J Immunol 175:3621(2005)
43. Hanada, K., J. W. Yewdell, J. C. Yang: Immune recognition of a human renal cancer antigen through posttranslational protein splicing. Nature 427:252(2004)
44. Vigneron, N., V. Stroobant, J. Chapiro, A. Ooms, G. Degiovanni, S. Morel, P. van der Bruggen, T. Boon, B. J. Van den Eynde: An antigenic peptide produced by peptide splicing in the proteasome. Science 304:587(2004)
45. Lanzavecchia, A.: Mechanisms of antigen uptake for presentation. Curr Opin Immunol 8:348(1996)
46. Regnault, A., D. Lankar, V. Lacabanne, A. Rodriguez, C. Thery, M. Rescigno, T. Saito, S. Verbeek, C. Bonnerot, P. Ricciardi-Castagnoli, S. Amigorena: Fcgamma receptormediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 189:371(1999)
47. Serreze, D. V., S. A. Fleming, H. D. Chapman, S. D. Richard, E. H. Leiter, R. M. Tisch: B lymphocytes are critical antigen-presenting cells for the initiation of T cellmediated autoimmune diabetes in nonobese diabetic mice. J Immunol 161:3912(1998)
48. Falcone, M., J. Lee, G. Patstone, B. Yeung, N. Sarvetnick: B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J Immunol 161:1163(1998)
49. Dai, Y., K. A. Carayanniotis, P. Eliades, P. Lymberi, P. Shepherd, Y. Kong, G. Carayanniotis: Enhancing or suppressive effects of antibodies on processing of a pathogenic T cell epitope in thyroglobulin. J Immunol 162:6987(1999)
50. Doyle, H. A., M. J. Mamula: Posttranslational modifications of self-antigens. Ann N Y Acad Sci 1050:1(2005)
51. Mamula, M. J., R. J. Gee, J. I. Elliott, A. Sette, S. Southwood, P. J. Jones, P. R. Blier: Isoaspartyl posttranslational modification triggers autoimmune responses to self-proteins. J Biol Chem 274:22321(1999)
52. Mannering, S. I., L. C. Harrison, N. A. Williamson, J. S. Morris, D. J. Thearle, K. P. Jensen, T. W. Kay, J. Rossjohn, B. A. Falk, G. T. Nepom, A. W. Purcell: The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J Exp Med 202:1191(2005)